
Allison Marvel
Director
Chicago Mergers & Acquisitions Healthcare amarvel@lincolninternational.com +1 (312) 628-1435I am motivated to produce tangible outcomes not just for clients and investors, but also for the benefit of patients and families receiving critical and often life-sustaining healthcare services.
Allison provides mergers and acquisitions (M&A) advisory to clients across the healthcare spectrum. Her experience includes buy-side and sell-side transactions and domestic and cross-border advisory for private equity firms and public and privately held companies.
Allison applies deep healthcare knowledge to help her clients capitalize on strategic M&A opportunities in the ever-changing healthcare landscape. She fosters relationships between buyers and sellers to achieve rewarding outcomes for both parties.
Prior to joining Lincoln, Allison spent five years as an Associate in KPMG’s Transaction Services Practice where she provided financial due diligence support to private equity and corporate clients.
Allison earned a Bachelor of Arts in economics and a Bachelor of Business Administration in accountancy from the University of Notre Dame. She also holds a Master of Business Administration from The University of Chicago Booth School of Business.
Perspectives featuring Allison Marvel

What’s Old is New Again: Value-Based Care Delivery in the Home
In 1930, physicians visiting patients in their residences represented 40 percent of all encounters. 20 years later this figure had fallen dramatically to just one visit in 10. By the… Read More

In a Post-COVID Climate, Home is Where the Care Is
The 65-and-older population has ballooned by over a third (34.2% or 13,787,044) during the past decade, according to the U.S. Census Bureau. With a growing pool of older Americans, investors… Read More
Meet our Senior Team

I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | Management Board Member
FrankfurtFirm details on FINRA’s BrokerCheck